Apatinib combined with docetaxel in second-line treatment of advanced gastric cancer: A prospective clinical study (data updated)

被引：1
|
作者：
Yang, M. [1 ]
Gao, J. [1 ]
Liu, X. [1 ]
Lu, H. [1 ]
机构：
[1] Shanxi Canc Hosp, Digest Dept Oncol, Taiyuan, Peoples R China
来源：
ANNALS OF ONCOLOGY | 2020年 / 31卷
关键词：
D O I：
10.1016/j.annonc.2020.08.1934
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1428P
引用
收藏
页码：S903 / S903
页数：1
相关论文
共 50 条
  • [41] SECOND-LINE DOCETAXEL (D) IN METASTATIC GASTRIC CANCER (MGC)
    Caparello, C.
    Lencioni, M.
    Vasile, E.
    Caponi, S.
    Santi, S.
    Fabrini, M. G.
    Ginocchi, L.
    Lucchesi, M.
    Ricci, S.
    Falcone, A.
    ANNALS OF ONCOLOGY, 2012, 23 : 251 - 251
  • [42] Docetaxel Second-line Therapy in Patients with Advanced Pancreatic Cancer: A Retrospective Study
    Saif, Muhammad Wasif
    Syrigos, Kostas
    Penney, Robin
    Kaley, Kristin
    ANTICANCER RESEARCH, 2010, 30 (07) : 2905 - 2909
  • [43] Second-line treatment of advanced gastric cancer with oxaliplatin plus raltitrexed
    Schmid, KE
    Kornek, GV
    Schüll, B
    Raderer, M
    Lenauer, A
    Depisch, D
    Lang, F
    Scheithauer, W
    ONKOLOGIE, 2003, 26 (03): : 255 - 258
  • [44] Docetaxel and irinotecan as second-line therapy for advanced oesophagogastric cancer
    Hawkes, Eliza
    Okines, Alicia F. C.
    Papamichael, Demetris
    Rao, Sheela
    Ashley, Sue
    Charalambous, Haris
    Koukouma, Alona
    Chau, Ian
    Cunningham, David
    EUROPEAN JOURNAL OF CANCER, 2011, 47 (08) : 1146 - 1151
  • [45] A real-world study comparing apatinib combined with irinotecan versus irinotecan as second-line or above therapy in patients with advanced or metastatic gastric cancer
    Nie, C.
    Lv, H.
    Chen, B.
    Xu, W.
    Wang, J.
    Wang, S.
    Liu, Y.
    He, Y.
    Zhao, J.
    Chen, X.
    ANNALS OF ONCOLOGY, 2022, 33 : S1474 - S1474
  • [46] Efficacy and safety of apatinib plus docetaxel as the second or above line treatment in advanced nonsquamous NSCLC A multi center prospective study
    Jiang, Qian
    Zhang, Ning-Ling
    Ma, Dai-Yuan
    Tan, Bang-Xian
    Hu, Xin
    Fang, Xiang-Dong
    MEDICINE, 2019, 98 (26) : e16065
  • [47] DOCETAXEL MONOTHERAPY AS A SECOND-LINE SALVAGE TREATMENT IN ADVANCED GASTRIC CANCER: EXPERIENCE OF 40 PATIENTS WITH PROGNOSTIC FACTOR ANALYSIS
    Llabres, Elisenda
    Javier Perez, Martin Francisco
    Calvo, Mariona
    Laquente, Berta
    Vazquez, Silvia
    Galan, Maica
    ANNALS OF ONCOLOGY, 2012, 23 : 49 - 49
  • [48] Second-line chemotherapy for advanced gastric cancer in Korea
    Sun Kyung Baek
    Si-Young Kim
    Jae-heon Jeong
    Kyung San Cho
    Hwi-Joong Yoon
    Gastric Cancer, 2012, 15 : 345 - 354
  • [49] Second-line chemotherapy for patients with advanced gastric cancer
    Daisuke Takahari
    Gastric Cancer, 2017, 20 : 395 - 406
  • [50] Is there a role for second-line chemotherapy in advanced gastric cancer?
    Wesolowski, Robert
    Lee, Chan
    Kim, Richard
    LANCET ONCOLOGY, 2009, 10 (09): : 903 - 912
12345